Glyceryl Trinitrate Gel Phonophoresis on Planter Fasciiatis
Effect of Glyceryl Trinitrate Gel Phonophoresis in Treatment of Plantar Fasciitis: A Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Does phonophoresis with glyceryl trinitrate gel have an effect in treatment of planter fasciitis patients?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2026
CompletedFirst Posted
Study publicly available on registry
March 18, 2026
CompletedStudy Start
First participant enrolled
April 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
March 24, 2026
March 1, 2026
5 months
March 14, 2026
March 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Ultrasonography
Patients with plantar fasciitis also typically have a thickened fascia. This change could be related to the reparative process of microtears, fiber degeneration, or edema. The average thickness of the plantar fascia in healthy individuals is between 2.2 and 3.6 mm. In patients with plantar fasciitis, it ranges from 4.6 to 6.1 mm. In general, individuals with a plantar fascia thicker than 4 mm are considered to have plantar fasciitis.
From enrollment to the end of treatment at 5 weeks
Secondary Outcomes (4)
visual analogue scale
From enrollment to the end of treatment at 5 weeks
6-Minu Walk Test
From enrollment to the end of treatment at 5 weeks
Smartphone apps
From enrollment to the end of treatment at 5 weeks
Arabic version of modified foot function index (FFI)
From enrollment to the end of treatment at 5 weeks
Study Arms (2)
Phonophoresis group
EXPERIMENTALUltrasound will be used in addition to topical glyceryl trinitrate gel and therapeutic exercises.
ultrasound only and Therapeutic exercises
ACTIVE COMPARATORInterventions
1. Patients will receive Phonophoresis with topical glyceryl trinitrate gel. Using pulsed ultrasound (2:1) with the frequency of 0.8 MHz and intensity of 1.5 W/CM for 10 minutes was dynamically administered for the patients in 10 every other day sessions. 2. Therapeutic exercises * Tibialis anterior strengthening (four sets of ten repetitions, with weights of 3 to 5 kg) * Plantar fascia stretching the patient was comfortably sitting on chair with tennis ball under his foot. Then he rolls the ball by moving his foot in forward and backward direction. * Stretching of the gastrocnemius and gastro soleus muscles by standing (standing calf stretch exercise, standing soleus muscle stretch exercise), the Achilles tendon by sitting (towel stretch exercise) , and the plantar fascia on a step (plantar fascia stretch exercise) . Patients were asked to do the exercises for four weeks, 10 times each morning and evening by counting up to 30
1. Patients will receive ultrasound at a frequency of 1.0 Hz and intensity of 1.2 watts/cm². Ten sessions were undertaken at a frequency of two sessions per week. 2. therapeutic exercises.
Eligibility Criteria
You may qualify if:
- Age between 18-44 years .
- Patients BMI 18.5 to 24.9 kg / m2.
- The diagnosis of PF appear clinically according to the history and physical - examination findings of point tenderness at or near the medial calcaneal insertion of the plantar fascia .
- Diagnosis of plantar fasciitis, with plantar fascia of more than 4 mm thickness as evaluated by ultrasonography.
- Painful symptoms lasting three months or more .
You may not qualify if:
- Diabetes mellitus, peripheral neuropathy, vasculitis and vasculopathy.
- Any pathology in ankle/foot (instability, arthritis, malignancy, acute infection, and skin disorders) .
- Pregnancy or lactation, coronary artery disease, hypertension, renal diseases and anemia .
- Atrophy/ scar or skin ulcers at the site of intervention.
- Patients with allergy to nitrates.
- Heart pacemaker use .
- Anticoagulant use and absence of coagulation disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo university
Cairo, Cairo Governorate, 11311, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
abeer Abdrahman Mohamed, Phd
Faculty of physical therapy, Cairo university, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer
Study Record Dates
First Submitted
March 14, 2026
First Posted
March 18, 2026
Study Start
April 30, 2026
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
March 24, 2026
Record last verified: 2026-03